News & Press Releases

Reuters featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan.

Member Joanne Hawana was quoted in a Reuters article about the FDA’s plans to restrict GLP-1 ingredients in non-approved compound drugs. The article reports on the agency’s potential enforcement actions involving Hims & Hers and broader regulatory scrutiny of compounded weight-loss medications.

The National Law Journal highlighted the addition of Robert Vlasis to Mintz. He joins as a Co-chair of the firm’s International Trade Commission practice, further strengthening the firm's intellectual property services.

Member Theresa Carnegie shared insights in a Law360 Healthcare Authority article about a federal government bulletin stating that drug manufacturers will be able to sell medications directly to patients through TrumpRx, without violating federal anti-kickback laws. The article sheds light on the potential legal risks associated with excluding telehealth providers, pharmacies, and other parties not covered by the bulletin.

Law360 highlighted the addition of Robert Vlasis to Mintz. The article noted Robert’s deep experience handling 337 Section investigations. He joins as a Co-chair of the firm’s International Trade Commission practice, further strengthening the firm's intellectual property services.

Utility Dive featured insights from Digital Infrastructure Co-chair Steven Shparber in an article focused on what to expect from FERC in 2026, including the agency’s focus on ensuring recent interconnection and transmission changes are successfully implemented.